Societe Generale Effekten (S27456) 시세

Approval Friday tomorrow?? I’m going with that.

Pleasure. Credibility here has never been an issue. Despite the time on EM they've been consistently solid in their endeavors and executions.
They don't belong on the OTC and the MMS campaign to subvert this is only going to cost them more as the forensics on shares plays into this uplist.

Going from .0043 to the .003's is decimation in your view?? You clearly weren't here over the past 4 years when the REAL decimation occurred.

I corrected it, but then put it back for all the sanctioned chicom cheeseheads on the board.

MULN.............................................................................................................grabthoseshares..........................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856

Thanks. I added Fintel to my bookmarks.

Interesting how different the reporting is compared to Nasdaq. Fintel says 290 institutional holders, Nasdaq says 183. Seems to be a difference in the definition of institution. The result is a 6 million shares held difference between the

GM LD!!

The way the market is for players 30 and older I don't see them getting long term deals.

Ty morg

IGNORE paid bashers that do not know how to read or absorb actual IFUS financials...

Better yet read a new Letter to IFUS Shareholders this morning

https://www.otcmarkets.com/otcapi/company/dns/news/document/80214/content


Always ignore paid basher

GNPX - $.50 - Worth watching on news out... Roughly 10 million in the float...

https://finance.yahoo.com/news/genprex-collaborators-nprl2-gene-therapy-131500736.html

Your +3.38% pre market open is shrinkiung fast and will end up down 5-10% before the day is out.

Thanks, me too, lol…

HUBS
HubSpot price target raised to $800 from $725 at TD Cowen
TD Cowen analyst Derrick Wood raised the firm's price target on HubSpot to $800 from $725 and keeps a Hold rating on the shares. The firm said seat expansions and downsell mitigation are helping drive NRR higher but SKU

FDCT Awesome 8k!

RCAT not ZENA is a real solid play in the space. ZENA has zero revenue in the space. RCAT see below.


Year End April 29 2024 2020 2021 2022 2023 2024

Total Revenue 404k 5.0M 6.43M 9.91M 17.84M

Link ???????

Ok now we’re talking. It was starting to seem like a typical stinky pinky but yeah I’ll admit an 8k proving uplist intent takes this to a whole new level.

That is how a company backs what they say and gives investors confidence that they will be moving forward.. Thanks for posting it

You’re not the sharpest knife in the drawer.
I’m going to say you have a big fat gut, losing your hair and try and pretend you play golf, if I was a to profile you in a crime, that’s what I would determine.

“Tom Bishop's questions were much better than anything ask by so called "analysts" in the past!”

So apparently you think the analysts’ price targets are worthless. On that point we agree.

Con